Drug Profile


Alternative Names: Moba; Mover; MS 932; Orcl

Latest Information Update: 03 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mitsubishi Chemical; Nippon Shinyaku
  • Developer Kowa Pharmaceutical; Mitsubishi Chemical; Nippon Shinyaku
  • Class Antirheumatics; Phenylacetates
  • Mechanism of Action Interleukin 2 modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Rheumatoid arthritis

Most Recent Events

  • 03 Nov 2006 Nikken Chemicals is now called Kowa Pharmaceutical
  • 29 Jan 2004 Nikken Chemicals has been acquired by Kowa
  • 30 Jul 1999 Profile reviewed but no significant changes made
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top